Merck (MRK) anti-baldness drug Propecia has long trail of suicide reports, records show - Reuters
- Tech stocks push S&P 500 to record close, buoy Nasdaq
- U.S. Calls for Pause of J&J (JNJ) Vaccine After Clotting Cases, Including One Death
- Coinbase (COIN) direct listing IPO reference price set at $250
- Biggest SPAC Deal Ever: Grab To Go Public in a $40 Billion Merger With Altimeter (AGC), Backed by Fidelity and BlackRock
- Oil rises after robust China data but J&J vaccine pause weighs
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Merck (NYSE: MRK) anti-baldness drug Propecia has long trail of suicide reports, records show - Reuters
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Joint CDC and FDA Statement on Johnson & Johnson (JNJ) COVID-19 Vaccine
- Companies with NDRs 4/13
- Citron Research was negative on Riot Blockchain (RIOT)
Create E-mail Alert Related CategoriesFDA, Hot FDA News, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!